GlaxoSmithKline and Aptuit, Inc. have finalized an agreement for Aptuit to acquire operations at GSK’s Medicines Research Centre in Verona, Italy. Effective July 1, Aptuit will retain the staff at the center and will supply GSK with R&D services from the facilities. Financial terms were not disclosed. “Aptuit was built to provide an integrated drug development capability and streamline the drug development process. This is a strategic acquisition of GSK’s research business in Verona that ...